Lower, more frequent cisplatin dosing minimizes hearing loss in head and neck cancer is a research paper published in JCI Insight (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Deafness and Other Communication Disorders
Grant: 1 ZIA DC000079
Intramural NIH HHS
Grant: ZIA DC000079
MeSH Terms
Keywords